[The German Society for Rheumatology and Clinical Immunology (DGRh) and the COVID-19 pandemic].

Autor: Voormann AJ; Deutsche Gesellschaft für Rheumatologie und Klinische Immunologie e. V., Wilhelmine-Gemberg-Weg 6, Aufgang C, 10179, Berlin, Deutschland., Specker C; Deutsche Gesellschaft für Rheumatologie und Klinische Immunologie e. V., Wilhelmine-Gemberg-Weg 6, Aufgang C, 10179, Berlin, Deutschland. specker@hhu.de.; Klinik für Rheumatologie und Klinische Immunologie, Evangelisches Krankenhaus, Kliniken Essen-Mitte, Pattbergstr. 2, 45239, Essen, Deutschland. specker@hhu.de.
Jazyk: němčina
Zdroj: Zeitschrift fur Rheumatologie [Z Rheumatol] 2024 Sep; Vol. 83 (7), pp. 520-527. Date of Electronic Publication: 2024 Jul 15.
DOI: 10.1007/s00393-024-01540-9
Abstrakt: The pandemic led to a global disruption of public life unprecedented in modern times due to an infectious disease, which certainly caused additional special burdens for patients with chronic diseases as well as for personnel in the healthcare system. The German Society of Rheumatology and Clinical Immunology (DGRh), with its Executive Board and two ad hoc commissions, responded promptly to the complex challenges posed by the pandemic for rheumatological care in Germany with provision of a comprehensive and professionally sound range of information and provided concrete assistance in many situations. The diverse activities of the DGRh in the context of the pandemic led to national and international attention and consideration of its committees and recommendations in national committees and guidelines.
(© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
Databáze: MEDLINE
Externí odkaz: